Adalimumab-AATY - Latest Advances

Disseminated Histoplasmosis Following a Single Dose of Adalimumab in a Child With Juvenile Idiopathic Arthritis: Case Report.

Journal: The Pediatric infectious disease journal

Published: December 16, 2025

HLA-DQA105:01 and DQA105:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: December 13, 2025

Disseminated Mycobacterium marinum presenting as bursitis in a patient with psoriatic arthritis on adalimumab.

Journal: JAAD case reports

Published: December 09, 2025

Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review.

Journal: Journal of cutaneous medicine and surgery

Published: December 05, 2025

From haircut to havoc: a teen's battle with multisite inflammatory disease.

Journal: Proceedings (Baylor University. Medical Center)

Published: December 04, 2025

Atypical waves: nonsporotrichoid Mycobacterium marinum skin infection in an immunocompromised scuba diver.

Journal: Skin health and disease

Published: November 28, 2025

An unusual case of cutaneous tuberculosis and paradoxical TB in a patient with spondyloarthritis treated with adalimumab.

Journal: The journal of the Royal College of Physicians of Edinburgh

Published: November 27, 2025

Concurrent granulomatous skin and nasal lesions likely induced by adalimumab for ulcerative colitis: a unique case of localized drug-induced granulomatosis.

Journal: European journal of dermatology : EJD

Published: November 24, 2025

Unmasking Neurosarcoidosis in a Patient With Acute Meningitis Features.

Journal: Cureus

Published: November 23, 2025

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.

Journal: Gastroenterology

Published: November 22, 2025

Efficacy of Adalimumab Biosimilars in Managing Perianal Fistula in Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis.

Journal: La Clinica terapeutica

Published: November 21, 2025

The Role of TNF - α, IFN - γ, and IL-6 in Guiding Treatment and Predicting Prognosis in the Treatment of Severe Plaque Psoriasis with Adalimumab.

Journal: Indian journal of dermatology

Published: November 20, 2025

Filters

Disseminated Histoplasmosis Following a Single Dose of Adalimumab in a Child With Juvenile Idiopathic Arthritis: Case Report.

Disseminated Histoplasmosis Following a Single Dose of Adalimumab in a Child With Juvenile Idiopathic Arthritis: Case Report.

HLA-DQA1*05:01 and DQA1*05:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.

HLA-DQA1*05:01 and DQA1*05:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.

Disseminated Mycobacterium marinum presenting as bursitis in a patient with psoriatic arthritis on adalimumab.

Disseminated Mycobacterium marinum presenting as bursitis in a patient with psoriatic arthritis on adalimumab.

Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review.

Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review.

From haircut to havoc: a teen's battle with multisite inflammatory disease.

From haircut to havoc: a teen's battle with multisite inflammatory disease.

Atypical waves: nonsporotrichoid Mycobacterium marinum skin infection in an immunocompromised scuba diver.

Atypical waves: nonsporotrichoid Mycobacterium marinum skin infection in an immunocompromised scuba diver.

An unusual case of cutaneous tuberculosis and paradoxical TB in a patient with spondyloarthritis treated with adalimumab.

An unusual case of cutaneous tuberculosis and paradoxical TB in a patient with spondyloarthritis treated with adalimumab.

Concurrent granulomatous skin and nasal lesions likely induced by adalimumab for ulcerative colitis: a unique case of localized drug-induced granulomatosis.

Concurrent granulomatous skin and nasal lesions likely induced by adalimumab for ulcerative colitis: a unique case of localized drug-induced granulomatosis.

Unmasking Neurosarcoidosis in a Patient With Acute Meningitis Features.

Unmasking Neurosarcoidosis in a Patient With Acute Meningitis Features.

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.

Efficacy of Adalimumab Biosimilars in Managing Perianal Fistula in Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis.

Efficacy of Adalimumab Biosimilars in Managing Perianal Fistula in Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis.

The Role of TNF - α, IFN - γ, and IL-6 in Guiding Treatment and Predicting Prognosis in the Treatment of Severe Plaque Psoriasis with Adalimumab.

The Role of TNF - α, IFN - γ, and IL-6 in Guiding Treatment and Predicting Prognosis in the Treatment of Severe Plaque Psoriasis with Adalimumab.

HLA-DQA105:01 and DQA105:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.

HLA-DQA105:01 and DQA105:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.